UCSF Chancellor Susan Desmond-Hellmann shares a story to illustrate how innovation occurs in the field of biotechnology. She describes the development of an innovative cancer drug at Genentech, even in the face of great skepticism, and the team effort it took to gain regulatory approval.
To read the full, original article click on this link: Stanford's Entrepreneurship Corner: Susan Desmond-Hellmann, UCSF - A Story of Biotech Innovation
